Euroopa Liit - eesti - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex on näidustatud kasutamiseks adjunctive ravi konfiskeerimiste seotud lennox gastaut sündroom (lgs) või dravet sündroom (ds), koos klobasaam, patsientidel, 2-aastased ja vanemad.

Euroopa Liit - eesti - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - hobuslaste immunoloogilised vahendid - hobused - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Euroopa Liit - eesti - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosupressandid - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Euroopa Liit - eesti - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuuria, paroksüsmaalne - immunosupressandid - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.

Eesti - eesti - Ravimiamet

baxalta innovations gmbh - inimese protrombiinkompleks - süstelahuse pulber ja lahusti - 500rÜ 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.